Filter Results
:
(90)
Show Results For
-
All HBS Web
(601)
- Faculty Publications (90)
Show Results For
-
All HBS Web
(601)
- Faculty Publications (90)
Cancer →
- September 2012
- Supplement
Intraoperative Radiotherapy for Breast Cancer (B)
By: Willy Shih
The intraoperative radiotherapy (IORT) business at Carl Zeiss Meditec had struggled with growth since the time of the (A) case. Though the unit had grown revenues in excess of 50% and had exceeded its EBIT target, it faced several key strategic choices. Should it...
View Details
Keywords:
Radiotherapy;
Breast Cancer;
Brachytherapy;
Therapeutic Radiation;
Oncology;
Oncology Treatment Systems;
Elekta AB;
Varian Medical Systems;
Xoft;
Electronic Brachytherapy;
Intraoperative Radiotherapy;
Disruptive Innovation;
Health Care and Treatment;
Entrepreneurship;
Technological Innovation;
Growth and Development Strategy;
Health Industry;
Germany
Shih, Willy. "Intraoperative Radiotherapy for Breast Cancer (B)." Harvard Business School Supplement 613-040, September 2012.
- August 2012 (Revised February 2021)
- Case
Hub and Spoke, HealthCare Global and Additional Focused Factory Models for Cancer Care
By: Regina E. Herzlinger, Amit Ghorawat, Meera Krishnan and Naiyya Saggi
This case compares and contrasts four different models for delivering cancer care in India and the US. Students are asked to select the best model in its alignment with the Six Forces in those two countries and Africa, to which one of the models is considering...
View Details
Keywords:
Cancer Care Services;
Focused Factories For Cancer Care;
Hub And Spoke Cancer Care;
Cancer Care In The U.S.;
Cancer Care In Africa;
Cancer Care In India;
Health Care and Treatment;
Business Model;
Six Sigma;
Health Disorders;
Health Industry;
United States;
India;
Africa
Herzlinger, Regina E., Amit Ghorawat, Meera Krishnan, and Naiyya Saggi. "Hub and Spoke, HealthCare Global and Additional Focused Factory Models for Cancer Care." Harvard Business School Case 313-030, August 2012. (Revised February 2021.)
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who...
View Details
Keywords:
Cancer;
Cancer Treatment;
Health Care;
Healthcare;
Accountability;
Outcomes;
Outcomes Measurement;
Outcomes Reporting;
Hub And Spoke Cancer Care;
Hub And Spoke;
Hub-and-spoke;
Focused Factory;
Mission and Purpose;
Private Ownership;
For-Profit Firms;
Health Disorders;
Medical Specialties;
Policy;
Business Model;
Expansion;
Decision Choices and Conditions;
Advertising;
Health Care and Treatment;
Innovation and Invention;
Health Industry;
United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- June 2012
- Teaching Note
Cancer Treatment Centers of America: Scaling the Mother Standard of Care (TN)
By: Rosabeth Moss Kanter and Matthew Bird
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into...
View Details
Keywords:
Health Care Industry;
Health Care Policy;
Organizational Transformations;
Health Services;
Health Care and Treatment;
Business Model;
Service Operations;
Change Management;
Corporate Strategy;
Information Technology;
Policy;
Pharmaceutical Industry;
Health Industry;
United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- December 2011 (Revised December 2011)
- Case
Cancer Treatment Centers of America: Scaling the Mother Standard of Care
By: Rosabeth Moss Kanter and Matthew Bird
The CEO of a private and growing national network of specialty care hospitals focusing on advanced-stage and complex cancer treatments reflected on the firm's past phase of growth before meeting with the company's Chairman and founder to discuss how to further scale...
View Details
Keywords:
Health Care and Treatment;
Business Growth and Maturation;
Medical Specialties;
Service Delivery;
Innovation and Invention;
Health Industry
Kanter, Rosabeth Moss, and Matthew Bird. "Cancer Treatment Centers of America: Scaling the Mother Standard of Care." Harvard Business School Case 312-073, December 2011. (Revised December 2011.)
- September 2011
- Supplement
Expansion at Narayana Hrudayalaya
By: Tarun Khanna and Tanya Bijlani
Narayana Hrudayalaya has expanded into a multi-specialty health city in Bangalore, with a 25-acre campus that offers complex tertiary care procedures ranging from orthopedics to cancer care. In 2008, NH raised private equity from JP Morgan and Pinebridge Investments to...
View Details
Keywords:
Investment;
Price;
Health Care and Treatment;
Emerging Markets;
Social Enterprise;
Expansion;
Health Industry;
Bangalore;
Cayman Islands;
Miami
Khanna, Tarun, and Tanya Bijlani. "Expansion at Narayana Hrudayalaya." Harvard Business School Video Supplement 712-801, September 2011.
- July 2011 (Revised September 2012)
- Case
Intraoperative Radiotherapy for Breast Cancer (A)
By: Willy Shih
"This trial is going to take longer." Those were words that Michael Kaschke, CEO of Carl Zeiss AG, was not surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to...
View Details
Keywords:
Finance;
Business History;
Disruptive Innovation;
Emerging Markets;
Organizational Change and Adaptation;
Research and Development;
Safety
Shih, Willy. "Intraoperative Radiotherapy for Breast Cancer (A)." Harvard Business School Case 612-003, July 2011. (Revised September 2012.)
- May 2011
- Article
The Power of Small Wins
By: Teresa M. Amabile and Steven J. Kramer
What is the best way to motivate employees to do creative work? Help them take a step forward every day. In an analysis of knowledge workers' diaries, the authors found that nothing contributed more to a positive inner work life (the mix of emotions, motivations, and...
View Details
Keywords:
Creativity;
Interpersonal Communication;
Employee Relationship Management;
Leadership;
Performance Effectiveness;
Emotions;
Motivation and Incentives;
Groups and Teams;
Collaborative Innovation and Invention;
Innovation Leadership;
Working Conditions;
Management Practices and Processes;
Management Skills;
Mission and Purpose;
Organizational Culture;
Performance Productivity;
Attitudes;
Behavior;
Happiness;
Perception;
Trust;
Time Management;
Resource Allocation;
Business or Company Management;
Goals and Objectives;
Managerial Roles
Amabile, Teresa M., and Steven J. Kramer. "The Power of Small Wins." Harvard Business Review 89, no. 5 (May 2011).
- January 2011 (Revised March 2011)
- Case
Predictive Biosciences
By: Thomas R. Eisenmann, Jeffrey J. Bussgang and David Kiron
A small cancer diagnostics start-up is deciding whether to acquire a laboratory to make and sell its bladder cancer test or build its own manufacturing and sales team.
View Details
Keywords:
Mergers and Acquisitions;
Factories, Labs, and Plants;
Business Startups;
Entrepreneurship;
Health Testing and Trials;
Growth and Development Strategy;
Product Development;
Biotechnology Industry
Eisenmann, Thomas R., Jeffrey J. Bussgang, and David Kiron. "Predictive Biosciences." Harvard Business School Case 811-015, January 2011. (Revised March 2011.)
- February 2010
- Teaching Note
Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan (TN)
By: Michael E. Porter and Jennifer F Baron
Teaching Note for [710425].
View Details
- December 2009 (Revised May 2012)
- Case
Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan
By: Michael E. Porter, Jennifer F Baron and C. Jason Wang
Taiwan's Koo Foundation Sun Yat-Sen Cancer Center has developed an integrated, team-based care delivery model for breast cancer care that is being expanded to other cancer types in 2009. A decade earlier, President and CEO Dr. Andrew Huang and the Center had worked...
View Details
Keywords:
Health Care and Treatment;
Medical Specialties;
Service Delivery;
Outcome or Result;
Performance Effectiveness;
Quality;
Integration;
Health Industry;
Insurance Industry;
Taiwan
Porter, Michael E., Jennifer F Baron, and C. Jason Wang. "Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan." Harvard Business School Case 710-425, December 2009. (Revised May 2012.)
- November 2009 (Revised August 2010)
- Case
NovoCure Ltd.
By: William A. Sahlman and Sarah Flaherty
Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor...
View Details
Keywords:
Financial Crisis;
Entrepreneurship;
Venture Capital;
Investment;
Health Care and Treatment;
Health Testing and Trials;
Technological Innovation;
Financial Services Industry
Sahlman, William A., and Sarah Flaherty. "NovoCure Ltd." Harvard Business School Case 810-045, November 2009. (Revised August 2010.)
- January 2009
- Teaching Note
Biocon: Launching a New Cancer Drug in India (TN)
By: Sunil Gupta and Das Narayandas
Teaching Note for [508026].
View Details
- January 2009 (Revised April 2017)
- Teaching Note
American Cancer Society: Access to Care
By: Robert Simons
Teaching Note for [109015].
View Details
- November 2008 (Revised October 2009)
- Case
American Cancer Society: Access to Care
By: Robert L. Simons and Kathryn Rosenberg
CEO John Seffrin decides to radically change the strategy of the American Cancer Society. The new Access to Care strategy relies on advocacy to change public policy and increase the number of Americans eligible for cancer prevention and treatment. The new strategy...
View Details
Keywords:
Values and Beliefs;
Governance Controls;
Leading Change;
Organizational Change and Adaptation;
Organizational Structure;
Nonprofit Organizations;
Business Strategy;
Health Industry;
United States
Simons, Robert L., and Kathryn Rosenberg. "American Cancer Society: Access to Care." Harvard Business School Case 109-015, November 2008. (Revised October 2009.)
- May 2008 (Revised April 2018)
- Case
The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care
By: Michael E. Porter and Sachin H. Jain
In 2006, University of Texas MD Anderson Cancer Center was an internationally leading institution for cancer care, education, and research. Since 1996, it had successfully reorganized itself from a cancer hospital that was physically organized around clinical...
View Details
Keywords:
Buildings and Facilities;
Health Disorders;
Organizational Structure;
Medical Specialties;
Organizational Change and Adaptation;
Value Creation;
Service Delivery;
Research;
Health Care and Treatment;
Education Industry;
Health Industry;
Texas
Porter, Michael E., and Sachin H. Jain. "The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care." Harvard Business School Case 708-487, May 2008. (Revised April 2018.)
- August 2007 (Revised November 2008)
- Case
Biocon: Launching a New Cancer Drug in India
By: Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
View Details
Keywords:
Price;
Health Care and Treatment;
Marketing Strategy;
Product Launch;
Planning;
Biotechnology Industry;
Pharmaceutical Industry;
India
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, August 2007. (Revised November 2008.)
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and...
View Details
Keywords:
Health Care and Treatment;
Strategic Planning;
Competition;
Patents;
Innovation and Invention;
Pharmaceutical Industry;
Biotechnology Industry;
United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- November 2005 (Revised March 2006)
- Case
Genentech - Capacity Planning
By: Daniel C. Snow, Steven C. Wheelwright and Alison Berkley Wagonfeld
While facilitating a complex clinical approval process over the next two to three years for a family of new cancer drugs, Genentech must develop a long-term capacity plan for a major class of new cancer products. Adding to the complexity and uncertainty is the fact...
View Details
Keywords:
Factories, Labs, and Plants;
Growth and Development Strategy;
Management Style;
Management Teams;
Time Management;
Product;
Product Development;
Business Processes;
Performance Capacity;
Planning;
Risk and Uncertainty;
Complexity;
Pharmaceutical Industry
Snow, Daniel C., Steven C. Wheelwright, and Alison Berkley Wagonfeld. "Genentech - Capacity Planning." Harvard Business School Case 606-052, November 2005. (Revised March 2006.)